COMMUNIQUÉS West-GlobeNewswire
-
Cadrenal Therapeutics to Showcase Phase 3-Ready CAD-1005 and Novel 12-LOX Platform at BIO International Convention 2026 Partnering Event
03/06/2026 -
Vital Nutrients Debuts Vital Nutrients Kids, a Practitioner-Grade Supplement Line Developed by Parents
03/06/2026 -
LiveWorld Launches LiveInsight AI™, Creating a New Category of Intelligence Systems for Pharma
03/06/2026 -
Novartis Cosentyx® PMR data in New England Journal of Medicine showed sustained remission vs placebo in twice as many patients
03/06/2026 -
Physicians Warned against Indemnification Clauses in Contracts, according to the Journal of American Physicians and Surgeons
03/06/2026 -
WORK Medical Technology Group Establishes U.S. Subsidiary to Advance Global Expansion and Reinforce Long-Term Growth Strategy
03/06/2026 -
Porch Light Health Launches Porch Light Health University to Expand Access to Practical Addiction Medicine Training
03/06/2026 -
Medical Grade Physiotherapy & Wellness Now Accepting New Clients in Burlington, Ontario — Redefining One-on-One Rehabilitation & Wellness Care
03/06/2026 -
VALNEVA : Déclaration d’actions et de droits de vote - Statut au 31 mai 2026
03/06/2026 -
Disclosure of transparency notification from FMR LLC
03/06/2026 -
MAIA Biotechnology Receives FDA Clearance to Open U.S. Enrollment in Ongoing Phase 2 THIO-101 Trial Expansion
03/06/2026 -
VALNEVA:Declaration of shares and voting rights - Status as of May 31, 2026
03/06/2026 -
LiveWorld Marks 30th Anniversary with Business Model Transformation & Launch of LiveInsight AI™ Intelligence System
03/06/2026 -
Curiox Automates Flow Cytometry Sample Prep End-to-End on a Single Instrument
03/06/2026 -
JenaValve Appoints Maria Jose Arana as Vice President of Quality and Compliance
03/06/2026 -
OneMedNet Surpasses 90 Million Patient Journeys and 270 Million Studies within its Network
03/06/2026 -
NYC Physician Dr. Felix Cohen Expands Access to Advanced Treatment for Women Suffering from Abnormal Uterine Bleeding and Dysmenorrhea
03/06/2026 -
CytomX Announces Expansion of Strategic Research Collaboration with Regeneron in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer
03/06/2026 -
SOTIO Receives U.S. FDA Orphan Drug Designation for SOT106, a Potential Best-in-Class ADC for Sarcoma
03/06/2026
Pages